BiotechTube
Home/Pipeline/Collaborative Program with Ferring

Collaborative Program with Ferring

Not Specified

ResearchActive

Key Facts

Indication
Not Specified
Phase
Research
Status
Active
Company
PharmaBiome

About PharmaBiome

PharmaBiome is a pre-clinical stage biotech pioneering a function-based approach to microbiome therapeutics. Originating from ETH Zurich, its platform focuses on engineering consortia of bacteria based on their metabolic interactions to restore core functions lost in dysbiosis. The company has established key R&D collaborations with industry partners like Ferring and Roquette and is advancing its science towards targeted therapies for inflammatory and other microbiome-linked conditions.

View full company profile

Therapeutic Areas

Inflammatory Bowel DiseaseGastrointestinal Disorders

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved